CTI BioPharma Corp. (CTIC): Price and Financial Metrics

CTIC POWR Grades

• Growth is the dimension where CTIC ranks best; there it ranks ahead of 82.72% of US stocks.
• CTIC's strongest trending metric is Value; it's been moving up over the last 177 days.
• CTIC's current lowest rank is in the Stability metric (where it is better than 2.44% of US stocks).

CTIC Stock Summary

• The capital turnover (annual revenue relative to shareholder's equity) for CTIC is -1.95 -- better than just 4.29% of US stocks.
• Equity multiplier, or assets relative to shareholders' equity, comes in at -9.98 for CTI BIOPHARMA CORP; that's greater than it is for only 2.11% of US stocks.
• As for revenue growth, note that CTIC's revenue has grown 1,332.03% over the past 12 months; that beats the revenue growth of 99.21% of US companies in our set.
• Stocks with similar financial metrics, market capitalization, and price volatility to CTI BIOPHARMA CORP are NH, QMCO, DESP, AVID, and FCEL.
• CTIC's SEC filings can be seen here. And to visit CTI BIOPHARMA CORP's official web site, go to www.ctibiopharma.com.

CTIC Valuation Summary

• In comparison to the median Healthcare stock, CTIC's price/sales ratio is 914.29% higher, now standing at 21.3.
• CTIC's price/sales ratio has moved up 3.5 over the prior 243 months.

Below are key valuation metrics over time for CTIC.

CTIC Growth Metrics

Its year over year net income to common stockholders growth rate is now at -104.79%.
• Its 4 year net income to common stockholders growth rate is now at 44.92%.
• Its 5 year net cashflow from operations growth rate is now at 44.15%.

CTIC's revenue has moved up $11,181,000 over the prior 67 months.

The table below shows CTIC's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	32.865	-95.702	-112.322
2022-06-30	14.624	-100.74	-120.796
2022-03-31	2.295	-98.089	-117.817
2021-12-31	0	-84.889	-97.908
2021-09-30	0	-65.691	-76.122
2021-06-30	0	-56.566	-63.206

CTIC's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• CTIC has a Quality Grade of C, ranking ahead of 52.35% of graded US stocks.
• CTIC's asset turnover comes in at 0 -- ranking 441st of 682 Pharmaceutical Products stocks.
• AIM, RIGL, and ICCC are the stocks whose asset turnover ratios are most correlated with CTIC.

The table below shows CTIC's key quality metrics over time.